Literature DB >> 2252898

Processing of newly synthesized cachectin/tumor necrosis factor in endotoxin-stimulated macrophages.

D M Jue1, B Sherry, C Luedke, K R Manogue, A Cerami.   

Abstract

The biosynthesis and processing of cachetin/tumor necrosis-factor (TNF) were examined in the murine macrophage-like cell line RAW 264.7. Lipopolysaccharide-stimulated cells secreted both glycosylated and nonglycosylated 17-kilodalton (kDa) mature cachectin/TNF into the culture medium. Secreted cachectin/TNF was derived from membrane-associated precursors that were precipitated by polyclonal antisera raised against either the mature protein or synthetic peptide fragments of the 79 amino acid cachectin/TNF prohormone sequence. About half of the precursors were N-glycosylated, apparently cotranslationally. The cachectin/TNF precursors were then proteolytically cleaved to release soluble mature cytokine into the medium, while the membrane-bound 14-kDa presequence remained cell associated. During the period of LPS stimulation, the amount of macrophage cell surface cachectin/TNF remained at a low level, suggesting that both nonglycosylated and glycosylated precursors of cachectin/TNF are efficiently cleaved by these cells. These findings suggest the presence of a unique mechanism for the secretion of cachectin/TNF.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2252898     DOI: 10.1021/bi00488a025

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  VIP36 protein is a target of ectodomain shedding and regulates phagocytosis in macrophage Raw 264.7 cells.

Authors:  Kyoko Shirakabe; Seisuke Hattori; Motoharu Seiki; Shigeo Koyasu; Yasunori Okada
Journal:  J Biol Chem       Date:  2011-10-20       Impact factor: 5.157

2.  A novel aminosaccharide compound blocks immune responses by Toll-like receptors and nucleotide-binding domain, leucine-rich repeat proteins.

Authors:  Kyoung-Hee Lee; Yuen-Joyce Liu; Amlan Biswas; Chikako Ogawa; Koichi S Kobayashi
Journal:  J Biol Chem       Date:  2010-12-07       Impact factor: 5.157

3.  Constitutive synthesis of tumor necrosis factor in the thymus.

Authors:  B P Giroir; T Brown; B Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

4.  A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in 'reverse signalling'.

Authors:  A D Watts; N H Hunt; Y Wanigasekara; G Bloomfield; D Wallach; B D Roufogalis; G Chaudhri
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

5.  Studies on the role of acid sphingomyelinase and ceramide in the regulation of tumor necrosis factor alpha (TNFalpha)-converting enzyme activity and TNFalpha secretion in macrophages.

Authors:  Krasimira A Rozenova; Gergana M Deevska; Alexander A Karakashian; Mariana N Nikolova-Karakashian
Journal:  J Biol Chem       Date:  2010-03-17       Impact factor: 5.157

6.  Oncogenic Ras stimulates Eiger/TNF exocytosis to promote growth.

Authors:  Chiswili Chabu; Tian Xu
Journal:  Development       Date:  2014-11-19       Impact factor: 6.868

7.  Natural human IgG inhibits the production of tumor necrosis factor-alpha and interleukin-1 alpha through the Fc portion.

Authors:  A Horiuchi; Y Abe; M Miyake; Y Osuka; S Kimura
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

8.  Myristyl acylation of the tumor necrosis factor alpha precursor on specific lysine residues.

Authors:  F T Stevenson; S L Bursten; R M Locksley; D H Lovett
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

9.  Chlorpromazine inhibits tumour necrosis factor synthesis and cytotoxicity in vitro.

Authors:  M Zinetti; G Galli; M T Demitri; G Fantuzzi; M Minto; P Ghezzi; R Alzani; E Cozzi; M Fratelli
Journal:  Immunology       Date:  1995-11       Impact factor: 7.397

10.  CNI-1493 inhibits monocyte/macrophage tumor necrosis factor by suppression of translation efficiency.

Authors:  P S Cohen; H Nakshatri; J Dennis; T Caragine; M Bianchi; A Cerami; K J Tracey
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.